Navigation Links
Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
Date:5/15/2008

HOUSTON - Celecoxib, the anti-inflammatory medication also known by the trade name Celebrex, has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung, according to a study from The University of Texas M. D. Anderson Cancer Center. This finding demonstrates the significance of COX-2 inhibition toward preventing lung cancer in individuals at higher risk of developing the disease.

The study is the first large randomized trial of Celebrex in lung cancer prevention; the findings will be presented at the American Society for Clinical Oncology's (ASCO) upcoming annual meeting as an oral presentation.

"With this study, in principal, we've been able to demonstrate the importance of COX-2 and the implications on inflammation pathway in lung cancer development," said Edward Kim, M.D., assistant professor in M. D. Anderson's Department of Thoracic Head and Neck Medical Oncology. "We've also been able to demonstrate that this drug class is safe and tolerable for this patient population. As we move forward in lung cancer chemoprevention, the importance of this class of drugs cannot be ignored."

From November 2001 to September 2006, the M. D. Anderson study enrolled 212 individuals, all of whom were current or former smokers with at least a 20-pack-year smoking habit. Most participants did not have any history of cancer; however, patients with a history of cancer who had been disease-free for six months could participate. The median age of participants was 53. The study examined levels of KI-67, a biomarker associated with precancerous lung lesions.

Participants underwent a baseline broncoscopy in which six predetermined biopsies were performed. They then were randomized to receive Celebrex at either 200 milligrams (low dose) or 400 milligrams (high dose) twice a day or placebo. After three months, participants received a second broncoscopy, the primary endpoint of the trial. Patients
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
832-264-8893
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Celebrex, Naproxen Wont Prevent Mental Decline
2. Celebrex Plus Lipitor Could Fight Prostate Cancer
3. Celebrex-Lipitor combo may halt prostate cancer
4. Having Less Power Impairs the Mind and Ability to Get Ahead, Study Shows
5. Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children
6. Avalere Report Shows Unapproved Prescription Drugs Dropped from CMS Formulary Reference File
7. New Survey Shows Americans Value Oral Health But Knowledge Gap Remains
8. Research shows HPV testing offers women protection for twice as long as smear testing
9. Study shows that prostate cancer increases the risk of bone fracture
10. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients with Diabetes Compared to Non-Diabetics in ARRIVE Registry Program
11. Mayo Clinic study shows acupuncture and myofascial trigger therapy treat same pain areas
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, a leading global provider ... it has hired Scott Sanderson, an experienced business development professional and former NFL ... responsible for establishing and managing new client relationships in the Southeast U.S. ...
(Date:9/1/2015)... New York, New York (PRWEB) , ... September 01, 2015 , ... ... of Zecurion Zlock Mac , its groundbreaking new version of endpoint DLP developed ... testing of Zlock Mac, in which more than 100 IT and information security professionals ...
(Date:9/1/2015)... ... September 01, 2015 , ... Two of Washington D.C.’s ... relations through food and dining. , Recently named “the next big thing” in ... are known for telling the whole story behind food and reclaiming culinary traditions on ...
(Date:9/1/2015)... ... September 01, 2015 , ... METTLER ... Instruments in accordance with GMP requirements“ , featuring Ed Szczesny (Quality Assurance, Rhodes ... at 11:00 EDT (15:00 GMT). , Calibration, qualification, and the appropriate level ...
(Date:9/1/2015)... ... ... Mercy Health (formerly Catholic Health Partners) – a Catholic healthcare ministry serving ... You Be Well videos to prostate cancer awareness. Prostate cancer is the most-common, non-skin ... on Mercy Health’s YouTube channel, Mercy Health experts address issues, such as:, ...
Breaking Medicine News(10 mins):Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:Zecurion Announces Endpoint Security for Mac 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 2Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 3Health News:Chefs Amy Riolo and Luigi Diotaiuti Embark on Culinary Diplomatic Quest to Build Bridges through Global Cuisine 4Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2
... Gift to The Leukemia & Lymphoma SocietyWHITE PLAINS, N.Y., April ... small, that mothers perform on behalf of their children and ... to do something special to pay tribute to mothers.Consider the ... There is nothing more terrifying for a mother than to ...
... Md., April 20 The following was released today by ... Ride for Dystonia - Debbi Mack and the Dystonia ... -- host the first Freedom Ride for Dystonia ... raise dystonia awareness and find a cure for this rare, ...
... work on research in molecular biology and physical sciences. This effort ... , ... Toronto, Ontario (PRWEB) April 20, 2009 -- ... team is world-wide, but mainly based in Europe and Canada. The ...
... questions people ask when choosing a Social Security representative , ... ... disability applicants can see benefits when they hire a representative to ... of thousands of people in the Social Security Disability Insurance ...
... Research Council (FRC) President Tony Perkins today released ... across the street from infamous late-term abortionist Dr. ... http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO )Perkins, ... life, urged opposition to the nomination of Kansas ...
... the University of California, San Diego and the Moores UCSD ... predict the aggressiveness of an often difficult-to-treat form of leukemia. ... the blood are an indicator that chronic lymphocytic leukemia (CLL) ... be aggressive and in need of immediate treatment. , ...
Cached Medicine News:Health News:This Mother's Day Celebrate a Mother's Love 2Health News:Maryland Mystery Author Organizes Fundraising Ride for Rare Neurological Disorder 2Health News:More Social Security Disability Applicants Are Seeking Representation 2Health News:More Social Security Disability Applicants Are Seeking Representation 3Health News:More Social Security Disability Applicants Are Seeking Representation 4Health News:More Social Security Disability Applicants Are Seeking Representation 5Health News:More Social Security Disability Applicants Are Seeking Representation 6Health News:FRC's Tony Perkins Challenges Sebelius' Integrity, Deep Ties to Late-Term Abortionist George Tiller 2Health News:New biomarker may predict leukemia aggressiveness 2
(Date:9/1/2015)... Mass. , Sept. 1, 2015   Millstone ... additional 120,000 square feet in Olive Branch, MS. ... Olive Branch facility has added the capacity ... space. "This expansion gives us the opportunity ... Neuberger , President of Millstone MS. "Two and a half ...
(Date:9/1/2015)... , Sept. 1, 2015   Ivenix Inc. ... infusion management system, closed on a $42M round ... Healthcare Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, ... in the round. This financing will support the ... market. Leerink Partners LLC acted as the exclusive ...
(Date:9/1/2015)... 2015 In nur zwei Jahren nach ... die SHL Group schnell weltweit 3.000 Mitarbeiter erreicht. ... auf dem Markt der injizierbaren Medikamente ... Management von SHL wieder. Foto - ... führend in Design und Herstellung automatischer Injektoren und ...
Breaking Medicine Technology:Millstone Medical Outsourcing Announces Olive Branch Expansion 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2
... March 30, 2011 Regado Biosciences, a privately held ... control agents, announced that David J. Mazzo, PhD, President ... Company,s 10th Annual Healthcare Conference at the New York ... 6, 2011 at 11:20 a.m. EDT.  The presentation will ...
... Inc. (Nasdaq: ABAX ), a medical products company ... chairman and chief executive officer,  will present at the 10th ... 8:40 a.m. ET. The conference will be held at the ... About Abaxis Abaxis develops, manufactures and markets portable blood ...
Cached Medicine Technology:Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City 2Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City 3
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
Cruciate retaining, posterior stabilized and constrained components....
The Natural-Knee Family is a complete range of interchangeable, anatomically-designed implants with over 14 years of proven clinical results....
...
Medicine Products: